Aethlon Medical, Inc. (AEMD) vs iSpecimen Inc. (ISPC)
A side-by-side comparison of Aethlon Medical, Inc. and iSpecimen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AEMD
Aethlon Medical, Inc.
$6.47HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
ISPC
iSpecimen Inc.
$1.03HealthcareDelayed quote: Oct 6, 2026, 10:02 AM EDT
Total return — AEMD vs ISPC
growth of $100 · dividends reinvested · last 5yAEMD -100.0% (-80.3%/yr)ISPC -100.0% (-82.1%/yr)AEMD compounded faster over this window
AEMD ISPC
AEMD vs ISPC: by the numbers
- •AEMD is the larger company ($3M vs $3M market cap).
- •Both run net losses; AEMD's is the smaller (0.00% vs -2449.04% net margin).
Metrics side by side
Valuation
| Metric | AEMD | ISPC |
|---|---|---|
| P/S ratio | N/A | 5.57 |
| P/B ratio | 0.66 | 1.50 |
Profitability
| Metric | AEMD | ISPC |
|---|---|---|
| Gross margin | 0.00% | 1.25% |
| Operating margin | 0.00% | -465.42% |
| Net margin | 0.00% | -2449.04% |
| ROE | -133.43% | -657.69% |
| ROIC | -133.29% | -476.39% |
Growth (annualized)
| Metric | AEMD | ISPC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -46.70% |
| Total return CAGR (5Y) | -78.27% | -81.14% |
Frequently asked
- How have AEMD and ISPC total returns compared?
- Over the past 5 years, AEMD delivered -78.27% and ISPC delivered -81.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.